| Year |
Citation |
Score |
| 2022 |
Wang P, Felsing DE, Chen H, Raval SR, Allen JA, Zhou J. Retraction of "Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists". Acs Medicinal Chemistry Letters. 13: 989. PMID 35707156 DOI: 10.1021/acsmedchemlett.2c00197 |
0.666 |
|
| 2020 |
Wang P, Felsing DE, Chen H, Stutz SJ, Murphy RE, Cunningham KA, Allen JA, Zhou J. Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior. Journal of Medicinal Chemistry. PMID 33198466 DOI: 10.1021/acs.jmedchem.0c01498 |
0.66 |
|
| 2019 |
Perry CK, Casey AB, Felsing DE, Vemula R, Zaka M, Herrington NB, Cui M, Kellogg GE, Canal CE, Booth RG. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT and 5-HT G protein-coupled receptor affinity, 3D-QSAR and molecular modeling. Bioorganic & Medicinal Chemistry. 115262. PMID 31882369 DOI: 10.1016/J.Bmc.2019.115262 |
0.35 |
|
| 2019 |
Land MA, Chapman HL, Davis-Reyes BD, Felsing DE, Allen JA, Moeller FG, Elferink LA, Cunningham KA, Anastasio NC. Serotonin 5-HT Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In Vitro. Scientific Reports. 9: 16737. PMID 31723224 DOI: 10.1038/S41598-019-53124-2 |
0.63 |
|
| 2019 |
Felsing DE, Jain MK, Allen JA. Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics. Current Topics in Medicinal Chemistry. 19: 1365-1380. PMID 31553283 DOI: 10.2174/1568026619666190712210903 |
0.689 |
|
| 2019 |
Wang P, Felsing DE, Chen H, Raval SR, Allen JA, Zhou J. Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists. Acs Medicinal Chemistry Letters. 10: 792-799. PMID 31098001 DOI: 10.1021/Acsmedchemlett.9B00050 |
0.69 |
|
| 2019 |
Felsing DE, Canal CE, Booth RG. Ligand-directed serotonin 5-HT receptor desensitization, β-arrestin recruitment, and sensitization. European Journal of Pharmacology. PMID 30689993 DOI: 10.1016/J.Ejphar.2019.01.037 |
0.351 |
|
| 2018 |
Felsing DE, Anastasio NC, Miszkiel JM, Gilbertson SR, Allen JA, Cunningham KA. Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction. Plos One. 13: e0203137. PMID 30157263 DOI: 10.1371/Journal.Pone.0203137 |
0.671 |
|
| 2018 |
Sampson CM, Kasper JM, Felsing DE, Raval SR, Ye N, Wang P, Patrikeev I, Rytting E, Zhou J, Allen JA, Hommel JD. Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models. Pharmacology Research & Perspectives. 6: e00425. PMID 30151213 DOI: 10.1002/Prp2.425 |
0.636 |
|
| 2017 |
Mongeau E, Yuan G, Minden Z, Waldron S, Booth R, Felsing D, Ondrechen MJ, Jones GB. Homology Modeling Inspired Synthesis of 5-HT2A Receptor Inhibitors: A Diazepine Analogue of the Atypical Antipsychotic JL13. Central Nervous System Agents in Medicinal Chemistry. PMID 28462720 DOI: 10.2174/1871524917666170426123607 |
0.439 |
|
| 2015 |
Canal CE, Felsing DE, Liu Y, Zhu W, Wood JT, Perry CK, Vemula R, Booth RG. Correction to An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models. Acs Chemical Neuroscience. PMID 26225542 DOI: 10.1021/Acschemneuro.5B00197 |
0.334 |
|
| 2015 |
Canal CE, Felsing DE, Liu Y, Zhu W, Wood JT, Perry CK, Vemula R, Booth RG. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models. Acs Chemical Neuroscience. PMID 26011730 DOI: 10.1021/Acschemneuro.5B00099 |
0.395 |
|
| 2014 |
Canal CE, Morgan D, Felsing D, Kondabolu K, Rowland NE, Robertson KL, Sakhuja R, Booth RG. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses. The Journal of Pharmacology and Experimental Therapeutics. 349: 310-8. PMID 24563531 DOI: 10.1124/Jpet.113.212373 |
0.49 |
|
| Show low-probability matches. |